117030280	117030280	CD	B-NP	O
|	|	IN	B-PP	O
GM	GM	NNP	B-NP	O
|	|	CC	O	O
64802666	64802666	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
057982	057982	CD	B-NP	O
|	|	CC	I-NP	O
1/10/1993	1/10/1993	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/9/1993	10/9/1993	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/13/1993	2/13/1993	CD	B-NP	O
SERVICE	SERVICE	NN	I-NP	O
:	:	:	O	O
MEDICINE	MEDICINE	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CHRONIC	CHRONIC	NN	B-NP	O
OBSTRUCTIVE	OBSTRUCTIVE	NN	I-NP	O
PULMONARY	PULMONARY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
EXACERBATION	EXACERBATION	NN	I-NP	O
.	.	.	O	O

PROBLEM	PROBLEM	NN	B-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

POLYMYALGIA	POLYMYALGIA	NNP	B-NP	O
RHEUMATICA	RHEUMATICA	NNP	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

LUMBAR	LUMBAR	NN	B-NP	O
DISK	DISK	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

HYPERTENSION	HYPERTENSION	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

COR	COR	NN	B-NP	O
PULMONALE	PULMONALE	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

TOBACCO	TOBACCO	NN	B-NP	O
SMOKER	SMOKER	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
PRESENT	PRESENT	JJ	I-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
62	62	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
somnolence	somnolence	NN	B-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
respiratory	respiratory	JJ	B-NP	O
acidosis	acidosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
intubations	intubation	NNS	I-NP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
active	active	JJ	I-NP	O
smoker	smoker	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jerald	Jerald	NNP	I-NP	O
Fenner	Fenner	NNP	I-NP	O
Most	Most	NNP	I-NP	O
recently	recently	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
8/5/92	8/5/92	CD	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
bronchodilators	bronchodilator	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
ABG	ABG	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
7.39	7.39	CD	B-NP	O
,	,	,	O	O
pC02	pC02	NN	B-NP	B-cell_line
51.1	51.1	CD	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
p02	p02	NN	I-NP	B-protein
of	of	IN	B-PP	O
66	66	CD	B-NP	O
with	with	IN	B-PP	O
91.3	91.3	CD	B-NP	O
%	%	NN	I-NP	O
02	02	CD	B-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
5/25	5/25	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
thyroid	thyroid	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
on	on	IN	B-PP	O
8/6	8/6	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
38	38	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
51	51	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
FEV1/FVC	FEV1/FVC	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mixed	mix	VBN	I-NP	O
obstructive/restrictive	obstructive/restrictive	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Theophylline	Theophylline	NN	B-NP	O
and	and	CC	I-NP	O
Proventil	Proventil	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
home	home	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
02	02	CD	B-NP	O
overnight	overnight	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
smoke	smoke	VB	I-VP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
frequent	frequent	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	O	O
productive	productive	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
postnasal	postnasal	JJ	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
denying	deny	VBG	B-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
cough	cough	NN	I-NP	O
or	or	CC	I-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
note	note	VB	I-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
increased	increase	VBN	I-NP	O
temperature	temperature	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
become	become	VB	I-VP	O
more	more	RBR	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Ward	Ward	NNP	I-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

There	There	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cyanotic	cyanotic	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
02	02	CD	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
59	59	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
first	first	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
on	on	IN	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
was	be	VBD	B-VP	O
7.27	7.27	CD	B-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
79	79	CD	I-NP	O
,	,	,	O	O
p02	p02	NN	B-NP	O
78	78	CD	I-NP	O
%	%	NN	I-NP	O
saturation	saturation	NN	I-NP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	NN	I-NP	O
flows	flow	VBZ	B-VP	O
after	after	IN	B-PP	O
three	three	CD	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	B-NP	O
90	90	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
become	become	VB	I-VP	O
somnolent	somnolent	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
showing	show	VBG	B-VP	O
a	a	DT	B-NP	O
pCO2	pCO2	NN	I-NP	O
of	of	IN	B-PP	O
94	94	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Was	Was	NNP	B-NP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma/COPD	asthma/COPD	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
polymyalgia	polymyalgia	NN	I-NP	I-protein
rheumatica	rheumatica	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
borderline	borderline	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
lumbar	lumbar	NN	I-NP	O
disk	disk	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
psoriasis	psoriasis	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
right	right	JJ	I-NP	O
sided	sided	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	SYM	B-NP	B-protein
7	7	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
sinusitis	sinusitis	NN	I-NP	O
,	,	,	O	O
-LRB-	-LRB-	NN	B-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
in	in	IN	B-PP	O
1979	1979	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
back	back	RB	B-ADVP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Theo-Dur	Theo-Dur	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
KCL	KCL	NN	B-NP	B-protein
,	,	,	O	O
Lodine	Lodine	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Proventil	Proventil	IN	B-PP	O
nebulizers	nebulizer	NNS	B-NP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
,	,	,	O	O
supplemental	supplemental	JJ	B-NP	O
02	02	CD	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
SHE	SHE	NNP	B-NP	O
IS	IS	NNP	I-NP	O
ALLERGIC	ALLERGIC	NNP	I-NP	O
TO	TO	NNP	I-NP	O
SULFA	SULFA	NNP	I-NP	O
WHICH	WHICH	NNP	I-NP	O
CAUSES	CAUSES	NNP	I-NP	O
HER	HER	NNP	I-NP	O
TO	TO	NNP	I-NP	O
HAVE	HAVE	NNP	I-NP	O
A	A	NNP	I-NP	O
RASH	RASH	NN	I-NP	B-protein
.	.	.	O	O

HABITS	HABITS	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
smoke	smoke	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
pack	pack	NN	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
two	two	CD	B-NP	O
sons	son	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
assisted	assist	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
intubated	intubated	JJ	I-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
female	female	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
140/70	140/70	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
70-100	70-100	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
101.6	101.6	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
Supple	Supple	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
I	I	NN	I-NP	O
:	:	:	O	O
E	E	NN	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
:	:	:	O	O
Tachycardiac	Tachycardiac	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Breasts	Breast	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-VP	O
deep	deep	VB	I-VP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
calves	calf	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
.	.	.	O	O

Pulses	Pulse	NNS	B-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
dorsalis	dorsalis	NN	I-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
neurological	neurological	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
lethargic	lethargic	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
difficult	difficult	JJ	I-ADJP	O
to	to	TO	B-VP	O
arouse	arouse	VB	I-VP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
all	all	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
reflexes	reflex	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
and	and	CC	O	O
symmetric	symmetric	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
138	138	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
36	36	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
10	10	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
113	113	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
9.96	9.96	CD	B-NP	O
,	,	,	O	O
76	76	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
lymphs	lymph	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
47.6	47.6	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
265	265	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
PT	PT	NN	I-NP	O
was	be	VBD	B-VP	O
11.4	11.4	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
PTT	PTT	NN	I-NP	B-protein
was	be	VBD	B-VP	I-protein
30.5	30.5	CD	B-NP	I-protein
.	.	.	O	O

Theophylline	Theophylline	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
5.3	5.3	CD	B-NP	O
.	.	.	O	O

ABG	ABG	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
as	as	RB	I-VP	O
mentioned	mention	VBN	I-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Post	Post	NNP	B-NP	O
intubation	intubation	NN	I-NP	O
,	,	,	O	O
ABG	ABG	NN	B-NP	O
7.45	7.45	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
41	41	CD	I-NP	O
,	,	,	O	O
p02	p02	NN	B-NP	O
57	57	CD	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
91	91	CD	B-NP	O
%	%	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
in	in	IN	B-PP	O
1/11	1/11	CD	B-NP	O
revealed	reveal	VBD	B-VP	O
mild	mild	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
heart	heart	NN	I-NP	O
size	size	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
infiltrates	infiltrate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
too	too	RB	B-ADJP	O
numerous	numerous	JJ	I-ADJP	O
to	to	TO	B-VP	O
count	count	VB	I-VP	O
white	white	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
eventually	eventually	RB	B-ADVP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
E.	E.	NNP	B-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
axis	axis	NN	I-NP	O
of	of	IN	B-PP	O
+8	+8	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
inverted	invert	VBD	B-VP	O
T	T	NN	B-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
11/1	11/1	CD	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	B-DNA
until	until	IN	B-PP	I-DNA
3/6/93	3/6/93	CD	B-NP	I-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aggressive	aggressive	JJ	B-NP	O
bronchodilator	bronchodilator	NN	I-NP	O
treatment	treatment	NN	I-NP	O
via	via	IN	B-PP	O
nebulizers	nebulizer	NNS	B-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
and	and	CC	I-NP	O
Atropent	Atropent	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Solu-Medrol	Solu-Medrol	NN	I-NP	O
dose	dose	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
tapered	taper	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
schedule	schedule	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Ceftriaxone	Ceftriaxone	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
tracheobronchitis	tracheobronchitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Ancef	Ancef	NN	I-NP	B-protein
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
Ceftriaxone	Ceftriaxone	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
essentially	essentially	RB	B-VP	O
was	be	VBD	I-VP	O
ready	ready	JJ	B-ADJP	O
for	for	IN	B-PP	O
extubation	extubation	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
on	on	IN	B-PP	O
3/6/93	3/6/93	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
watched	watch	VBN	I-VP	O
overnight	overnight	RB	B-ADVP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
6/14/93	6/14/93	CD	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
02	02	CD	I-NP	O
saturations	saturation	NNS	I-NP	O
were	be	VBD	B-VP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
peak	peak	NN	I-NP	O
flows	flow	NNS	I-NP	O
were	be	VBD	B-VP	O
improving	improve	VBG	I-VP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
Albuterol	Albuterol	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
Atrovent	Atrovent	JJ	B-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
polymyalgia	polymyalgia	NN	I-NP	O
rheumatica	rheumatica	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
adequately	adequately	RB	I-VP	O
treated	treat	VBN	I-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
repeat	repeat	NN	I-NP	O
cultures	culture	NNS	I-NP	O
growing	grow	VBG	B-VP	O
5	5	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
Staph	Staph	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
also	also	RB	B-ADVP	O
growing	grow	VBG	B-NP	O
diphtheroids	diphtheroid	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
clean	clean	JJ	B-NP	O
catches	catch	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
it	it	PRP	B-NP	O
repeated	repeat	VBD	B-VP	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
time	time	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
clean	clean	JJ	I-NP	O
catch	catch	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
grow	grow	VB	I-VP	O
probable	probable	JJ	B-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
exact	exact	JJ	I-NP	O
speciation	speciation	NN	I-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
last	last	JJ	I-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
5/17/93	5/17/93	NN	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
white	white	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
I	I	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
culture	culture	NN	I-NP	O
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
straight	straight	JJ	I-NP	O
cath	cath	NN	I-NP	O
specimen	specimen	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
informed	inform	VBN	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
dysuria	dysuria	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
persist	persist	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Gigger	Gigger	NNP	I-NP	O
immediately	immediately	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
that	that	IN	B-NP	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
noninfected	noninfected	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
1/16/93	1/16/93	CD	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturations	saturation	NNS	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
46	46	CD	B-NP	O
%	%	NN	I-NP	O
during	during	IN	B-PP	O
REM	REM	NN	B-NP	O
sleep	sleep	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
point	point	NN	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
breathing	breathing	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
element	element	NN	I-NP	O
of	of	IN	B-PP	O
essential	essential	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
during	during	IN	B-PP	O
periods	period	NNS	B-NP	O
of	of	IN	B-PP	O
non-REM	non-REM	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
alternated	alternate	VBN	B-VP	O
between	between	IN	B-PP	O
breathing	breathing	NN	B-NP	O
against	against	IN	B-PP	O
an	an	DT	B-NP	O
obstruction	obstruction	NN	I-NP	O
and	and	CC	B-NP	O
not	not	RB	I-NP	O
breathing	breathing	NN	B-NP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Progesterone	Progesterone	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
8/19/93	8/19/93	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
continued	continued	JJ	I-NP	O
good	good	JJ	I-NP	O
airflow	airflow	NN	I-NP	O
and	and	CC	O	O
much	much	RB	B-ADJP	O
fewer	few	JJR	I-ADJP	O
wheezes	wheeze	VBZ	B-VP	O
than	than	IN	B-PP	O
previously	previously	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Progesterone	Progesterone	NN	B-NP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
cc	cc	NN	I-NP	O
in	in	IN	B-PP	O
2.5	2.5	CD	B-NP	O
normal	normal	JJ	I-NP	O
saline	saline	NN	I-NP	O
q4	q4	NN	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhaler	IN	B-PP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
q4	q4	NN	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
tapering	taper	VBG	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
with	with	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
home	home	NN	B-NP	O
02	02	CD	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
Ampicillin	Ampicillin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lodine	Lodine	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Theo-Dur	Theo-Dur	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
KCL	KCL	NN	B-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cormany	Cormany	NNP	I-NP	O
on	on	IN	B-PP	O
3/17/93	3/17/93	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
cataracts	cataract	NNS	I-NP	O
by	by	IN	B-PP	O
Ophthalmology	Ophthalmology	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
LACY	LACY	NNP	B-NP	O
V.	V.	NNP	I-NP	O
GRANDI	GRANDI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
JH7	JH7	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CRISTOPHER	CRISTOPHER	NNP	B-NP	O
J.	J.	NNP	I-NP	O
STOREY	STOREY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VM4	VM4	NNP	I-NP	O
DJ114/7129	DJ114/7129	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
2156	2156	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

OASUYP9AQM	OASUYP9AQM	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/5/93	7/5/93	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/24/93	10/24/93	CD	B-NP	O

